Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Cyclophosphamide in Lupus Nephritis Induction and Maintenance
NCT00615173Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2006
- Primary completion
- Sep 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in lupus nephritis (LN) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Remission Rate at 6 months. Started Jul 2006; status: completed.
02
Drugs
tacrolimus
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00615173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615173.